NEITHER THIS
WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED. SUBJECT TO SECTION 6 BELOW, NO SALE OR
DISPOSITION MAY BE EFFECTED EXCEPT IN COMPLIANCE WITH RULE 144
UNDER SAID ACT OR WITHOUT AN EFFECTIVE REGISTRATION STATEMENT
RELATED THERETO OR AN OPINION OF COUNSEL FOR HOLDER, SATISFACTORY
TO COMPANY, THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT OR
RECEIPT OF A NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE
COMMISSION.
WARRANT TO PURCHASE 89,074 SHARES
OF COMMON STOCK
|
Warrant
No. CSW-08-022
|
October 14, 2008
|
THIS
CERTIFIES THAT , for
value received, GE Capital Equity Investments, Inc. (“
Holder ”) is entitled to subscribe for and purchase
Eighty-Nine Thousand Seventy Four (89,074) shares of fully paid and
nonassessable Common Stock of Cytori Therapeutics Inc., a Delaware
corporation (the “ Company ”), at the Warrant
Price (as hereinafter defined), subject to the provisions and upon
the terms and conditions hereinafter set forth. As used
herein, the term “Common Stock” shall mean
Company’s presently authorized common stock, $0.001 par value
per share, and any stock into which such common stock may hereafter
be converted or exchanged and the term “Warrant Shares”
shall mean the shares of Common Stock which Holder may acquire
pursuant to this Warrant and any other shares of stock into which
such shares of Common Stock may hereafter be converted or
exchanged.
1.
Warrant Price . The “Warrant Price”
shall initially be Four and 21 dollars ($4.21) per share, subject
to adjustment as provided in Section 7 below.
2.
Conditions to Exercise . The purchase right
represented by this Warrant may be exercised at any time, or from
time to time, in whole or in part during the term commencing on the
date hereof and ending at 5:00 P.M. Pacific time on the tenth
anniversary of the date of this Warrant (the “ Expiration
Date ”).
3.
Method of Exercise or Conversion; Payment; Issuance of Shares;
Issuance of New Warrant.
(a)
Cash Exercise . Subject to Section 2 hereof,
the purchase right represented by this Warrant may be exercised by
Holder hereof, in whole or in part, by the surrender of the
original of this Warrant (together with a duly executed Notice of
Exercise in substantially the form attached hereto) at the
principal office of Company (as set forth in Section 19 below)
and by payment to Company, by certified or bank check, or wire
transfer of immediately available funds, of an amount equal to the
then applicable Warrant Price per share multiplied by the number of
Warrant Shares then being purchased. In the event of any
exercise of the rights represented by this Warrant, certificates
for the shares of stock so purchased shall be in the name of, and
delivered to, Holder hereof, or as such
Holder may
direct (subject to the terms of transfer contained herein and upon
payment by such Holder hereof of any applicable transfer
taxes). Such delivery shall be made within 30 days
after exercise of this Warrant and at Company’s expense and,
unless this Warrant has been fully exercised or expired, a new
Warrant having terms and conditions substantially identical to this
Warrant and representing the portion of the Warrant Shares, if any,
with respect to which this Warrant shall not have been exercised,
shall also be issued to Holder hereof within 30 days after
exercise of this Warrant.
(b)
Conversion . In lieu of exercising this
Warrant as specified in Section 3(a), Holder may from time to time
convert this Warrant, in whole or in part, into Warrant
Shares by surrender of the original of this Warrant
(together with a duly executed Notice of Exercise in substantially
the form attached hereto) at the principal office of Company, in
which event Company shall issue to Holder the number of Warrant
Shares computed using the following formula:
X = the number
of Warrant Shares to be issued to Holder.
Y = the number
of Warrant Shares purchasable under this Warrant (at the date of
such calculation).
A = the Fair
Market Value of one share of Company’s Common Stock (at the
date of such calculation).
B = Warrant
Price (as adjusted to the date of such calculation).
(c)
Fair Market Value . For purposes of this
Section 3, Fair Market Value of one share of Company’s
Common Stock shall mean:
(i) The
average of the closing bid and asked prices of Common Stock quoted
in the Over-The-Counter Market Summary, the last reported sale
price quoted on the Nasdaq Stock Market or on any other exchange on
which the Common Stock is listed, whichever is applicable, as
published in the Western Edition of the Wall Street Journal
for the ten (10) trading days prior to the date of
determination of Fair Market Value; or
(ii) In
the event of an exercise in connection with a merger, acquisition
or other consolidation in which Company is not the surviving
entity, the per share Fair Market Value for the Common Stock shall
be the value to be received per share of Common Stock by all
holders of the Common Stock in such transaction as determined by
the Board of Directors; or
(iii) In
any other instance, the per share Fair Market Value for the Common
Stock shall be as determined in the reasonable good faith judgment
of Company’s Board of Directors.
In the event of
3(c)(ii) or 3(c)(iii), above, Company’s Board of Directors
shall prepare a certificate, to be signed by an authorized officer
of Company, setting forth in reasonable detail the basis for and
method of determination of the per share Fair Market Value of the
Common Stock. The Board of Directors will also certify
to Holder that this per share Fair Market Value will be applicable
to all holders of Company’s Common Stock. Such
certification must be made to Holder at least ten (10)
business days prior to the proposed effective date of the
merger, consolidation, sale, or other
triggering
event as defined in 3(c)(ii) or 3(c)(iii).
(d)
Automatic Exercise . To the extent this Warrant
is not previously exercised, it shall be deemed to have been
automatically converted in accordance with Sections 3(b)
and 3(c) hereof (even if not surrendered) as of immediately
before its expiration, involuntary termination or cancellation if
the then-Fair Market Value of a Warrant Share exceeds the
then-Warrant Price, unless Holder notifies Company in writing to
the contrary prior to such automatic exercise.
(e)
Treatment of Warrant Upon Acquisition of Company
.
(i)
Certain Definitions . For the purpose of this
Warrant, "Acquisition" means any sale, exclusive license, or other
disposition of all or substantially all of the assets of Company,
or any reorganization, consolidation, or merger of Company, or sale
of outstanding Company securities by holders thereof, where the
holders of Company's securities before the transaction beneficially
own less than a majority of the outstanding voting securities of
the successor or surviving entity after the
transaction. For purposes of this Section 3(e),
“Affiliate” shall mean any person or entity that owns
or controls directly or indirectly ten percent (10%) or more of the
voting capital stock of Company, any person or entity that controls
or is controlled by or is under common control with such persons or
entities, and each of such person’s or entity’s
officers, directors, joint venturers or partners, as
applicable.
(ii)
Cash Acquisition . In the event of an Acquisition
in which the sole consideration is cash, Holder may either
(a) exercise its conversion or purchase right under this
Warrant and such exercise will be deemed effective immediately
prior to the consummation of such Acquisition or (b) permit
the Warrant to expire automatically upon the consummation of such
Acquisition. Company shall provide Holder with written
notice of any proposed Acquisition together with such reasonable
information as Holder may request in connection with such
contemplated Acquisition giving rise to such notice, which is to be
delivered to Holder not less than ten (10) business days prior to
the closing of the proposed Acquisition.
(iii)
Asset Sale . In the event of an Acquisition that
is an arms length sale of all or substantially all of
Company’s assets (and only its assets) to a third party that
is not an Affiliate of Company (a “ True Asset Sale
”), Holder may either (a) exercise its conversion or
purchase right under this Warrant and such exercise will be deemed
effective immediately prior to the consummation of such Acquisition
or (b) permit the Warrant to continue until the Expiration
Date if Company continues as a going concern following the closing
of any such True Asset Sale. Company shall provide
Holder with written notice of any proposed asset sale together
with such reasonable information as Holder may request in
connection with such asset sale giving rise to such notice, which
is to be delivered to Holder not less than ten (10) business days
prior to the closing of the proposed asset sale.
(iv)
Assumption of Warrant . Upon the closing of any
Acquisition other than those particularly described in subsections
(ii) and (iii) above, the successor entity shall assume
the obligations of this Warrant, and this Warrant shall be
exercisable for the same securities, cash, and property as would be
payable for the Warrant Shares issuable upon exercise of the
unexercised portion of this Warrant as if such Warrant Shares were
outstanding on the record date for the Acquisition and subsequent
closing. The Warrant Price and/or number of Warrant
Shares shall be adjusted accordingly.
(v)
Early Termination of Warrant in Certain Other Circumstances
. Notwithstanding the
foregoing
provisions of Section 3(e)(iv), but subject to the terms of Section
3(d), in the event that the acquiror in an Acquisition does not
agree to assume this Warrant at and as of the closing of such
Acquisition, this Warrant, to the extent not exercised or converted
on or prior to such closing, shall terminate and be of no further
force or effect as of immediately following the closing of such
Acquisition if all of the following conditions are met: (A) the
acquiror is subject to the reporting requirements of Section 13 or
Section 15(d) of the Securities Exchange Act of 1934, as amended
(the “ Exchange Act ”), (B) the class of stock
or other security of the acquiror that would be received by Holder
in connection with such Acquisition were Holder to exercise or
convert this Warrant on or prior to the closing thereof is listed
for trading on a national securities exchange or approved for
quotation on an automated inter-dealer quotation system, and
(C) the value (determined as of the closing of such
Acquisition in accordance with the definitive agreements therefor)
of the acquiror stock and/or other securities that would be
received by Holder in respect of each Warrant Share were Holder to
exercise or convert this Warrant on or prior to the closing of such
Acquisition is equal to or greater than three (3) times the
then-effective Warrant Price.
4.
Representations and Warranties of Holder and
Company.
(a)
Representations and Warranties by Holder . Holder
represents and warrants to Company as follows:
(i)
Evaluation . Holder has substantial experience in
evaluating and investing in private placement transactions of
securities of companies similar to Company so that Holder is
capable of evaluating the merits and risks of its investment in
Company and has the capacity to protect its interests.
(ii)
Resale . Except for transfers to an affiliate of
Holder, Holder is acquiring this Warrant and the Warrant Shares
issuable upon exercise of this Warrant (collectively the “
Securities ”) for investment for its own account and
not with a view to, or for resale in connection with, any
distribution thereof. Holder does not presently have any
agreement, plan or understanding, directly or indirectly, with any
person to distribute or effect the distribution of any of the
Securities to or through any person. Holder understands
that the Securities have not been registered under the Securities
Act of 1933, as amended (the “ Act ”) by reason
of a specific exemption from the registration provisions of the Act
which depends upon, among other things, the bona fide nature of the
investment intent as expressed herein.
(iii)
Rule 144 . Holder acknowledges that the
Securities must be held indefinitely unless subsequently registered
under the Act or an exemption from such registration is
available. Holder is aware of the provisions of
Rule 144 promulgated under the Act.
(iv)
Accredited Investor . Holder is an
“accredited investor” within the meaning of Regulation
D promulgated under the Act.
(v)
Opportunity To Discuss . Holder has had an
opportunity to discuss Company’s business, management and
financial affairs with its management and an opportunity to review
Company’s facilities. Holder understands that such
discussions, as well as the written information issued by Company,
were intended to describe the aspects of Company’s business
and prospects which Company believes to be material but were not
necessarily a thorough or exhaustive description.
(b)
Representations and Warranties by Company
. Company hereby represents and warrants
to
Holder that the
statements in the following paragraphs of this Section 4(b) are
true and correct as of the date hereof.
(i)
Corporate Organization and Authority . Company
(a) is a corporation duly organized, validly existing, and in good
standing in its jurisdiction of incorporation; (b) has the
corporate power and authority to own and operate its properties and
to carry on its business as now conducted and as currently proposed
to be conducted; and (c) is qualified as a foreign corporation in
all jurisdictions where such qualification is required.
(ii)
Corporate Power . Company has all requisite
corporate power and authority to execute, issue and deliver this
Warrant, to issue the Warrant Shares issuable upon exercise or
conversion of this Warrant, and to carry out and perform its
obligations under this Warrant and any related
agreements.
(iii)
Authorization; Enforceability . All corporate
action on the part of Company, its officers, directors and
shareholders necessary for the authorization, execution, delivery
and performance of its obligations under this Warrant and for the
authorization, issuance and delivery of this Warrant and the
Warrant Shares issuable upon exercise of this Warrant has been
taken and this Warrant constitutes the legally binding and valid
obligation of Company enforceable in accordance with its
terms.
(iv)
Valid Issuance of Warrant and Warrant Shares
. This Warrant has been validly issued and is free of
restrictions on transfer other than restrictions on transfer set
forth herein and under applicable state and federal securities
laws. The Warrant Shares issuable upon conversion of this Warrant,
when issued, sold and delivered in accordance with the terms of
this Warrant for the consideration expressed herein, will be duly
and validly issued, fully paid and nonassessable, and will be free
of restrictions on transfer other than restrictions on transfer
under this Warrant and under applicable state and federal
securities laws. Subject to applicable restrictions on
transfer, the issuance and delivery of this Warrant and the Warrant
Shares issuable upon exercise or conversion of this Warrant are not
subject to any preempti